Trials / Conditions / Metastatic Prostate Small Cell Neuroendocrine Carcinoma
Metastatic Prostate Small Cell Neuroendocrine Carcinoma
3 registered clinical trials studyying Metastatic Prostate Small Cell Neuroendocrine Carcinoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Pr NCT05691465 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer NCT04754425 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted NCT03866382 | National Cancer Institute (NCI) | Phase 2 |